PlainPharmaWatch

CMS Open Payments · Tool

Exeltis, USA Inc. vs Integrity Orthopaedics, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Integrity Orthopaedics, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 1,500, versus 519 for the other company. Its single largest recorded recipient represents 0.2% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Exeltis, USA Inc.
HHI 519 · top recipient 0.2%
Ranked #1,278 of 1,838 companies by HHI
Integrity Orthopaedics, Inc.
HHI 1,500 · top recipient 0.2%
Ranked #861 of 1,838 companies by HHI

Payment Overview

Company A

Exeltis, USA Inc.

Total Payments
$7.7M
% of Industry
0.1%
Transactions
18,860
Avg per Transaction
$407.64
Recipients
17,662
Avg per Recipient
$435.29
Payment Types
4
Top Payment Type
Food and Beverage
Total Payments
$7.7M
% of Industry
0.1%
Transactions
186
Avg per Transaction
$41.5K
Recipients
173
Avg per Recipient
$44.6K
Payment Types
5
Top Payment Type
Food and Beverage

Highlighted values indicate the higher figure for each metric.

Total payments compared

Exeltis, USA Inc. vs Integrity Orthopaedics, Inc. - total reported payments in CMS Open Payments PY2024

Integrity Orthopaedics, Inc.$7.7MExeltis, USA Inc.$7.7M

Payment Types Breakdown

Exeltis, USA Inc.

Food and Beverage $345.7K

4.5%

Consulting Fee $205.3K

2.7%

Compensation for Services Other Than Consulting $139.2K

1.8%

Travel and Lodging $13.7K

0.2%

Integrity Orthopaedics, Inc.

Food and Beverage $11.1K

0.1%

Space Rental or Facility Fees $8.8K

0.1%

Travel and Lodging $8.5K

0.1%

Consulting Fee $5.5K

0.1%

Royalty or License $4.8K

0.1%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Exeltis, USA Inc.

  1. 1

    CATHERINE HANSEN

    $122,306.89 · 36 txns

  2. 2

    YOUSSEF MOUHAYAR

    $83,643.54 · 17 txns

  3. 3

    MICHAEL KRYCHMAN

    $46,946.13 · 1 txns

  4. 4

    JENNIFER ELLIOTT

    $27,208.29 · 11 txns

  5. 5

    JORDAN W NEIGHBORS

    $21,963.72 · 21 txns

Integrity Orthopaedics, Inc.

  1. 1

    Carolinas Medical Center

    $8,781.60 · 1 txns

  2. 2

    Stephen Porter Wiseman

    $7,776.79 · 18 txns

  3. 3

    Marc Robert Labbe

    $7,417.67 · 36 txns

  4. 4

    Howard Walker Harris

    $4,217.48 · 34 txns

  5. 5

    Patrick Michael Connor

    $3,526.05 · 15 txns

Summary Comparison

Metric Exeltis, USA Inc. Integrity Orthopaedics, Inc.
Total Payments $7.7M $7.7M
% of Industry Total 0.1% 0.1%
Transaction Count 18,860 186
Avg per Transaction $407.64 $41.5K
Recipient Count 17,662 173
Avg per Recipient $435.29 $44.6K
Payment Type Count 4 5
Top Payment Type Food and Beverage Food and Beverage

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.